Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age

MLA

de Kraker, Jan, et al. “Iodine-131-Metaiodobenzylguanidine as Initial Induction Therapy in Stage 4 Neuroblastoma Patients over 1 Year of Age.” European Journal of Cancer, vol. 44, no. 4, Mar. 2008, pp. 551–56. EBSCOhost, https://doi.org/10.1016/j.ejca.2008.01.010.

APA

de Kraker, J., Hoefnagel, K. A., Verschuur, A. C., van Eck, B., van Santen, H. M., & Caron, H. N. (2008). Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age. European Journal of Cancer, 44(4), 551–556. https://doi.org/10.1016/j.ejca.2008.01.010

Chicago

de Kraker, Jan, Kees A. Hoefnagel, Arnauld C. Verschuur, Berthe van Eck, Hanneke M. van Santen, and Huib N. Caron. 2008. “Iodine-131-Metaiodobenzylguanidine as Initial Induction Therapy in Stage 4 Neuroblastoma Patients over 1 Year of Age.” European Journal of Cancer 44 (4): 551–56. doi:10.1016/j.ejca.2008.01.010.